CRVO · Stock research · Public disclosure research
CervoMed Inc.
Data as of Jun 15, 2026. Collected disclosures, not exhaustive history.
30-day and 12-month windows end Oct 15, 2026 and use transaction dates, not disclosure dates. The data-as-of date above reflects the latest collected disclosure and may be older than the window end.
| BOGER JOSHUA SDirector, 10% Owner | Open-market purchaseNon-derivative security10b5-1 plan not indicated | 955,414 | $3.14 | $2,999,999.96 | 1,795,865 | Jun 11, 2026 | Jun 15, 2026SEC filing |
| BOGER JOSHUA SDirector, 10% Owner | Open market purchaseDerivative security10b5-1 plan not indicated | 955,414 | — | — | 955,414 | Jun 11, 2026 | Jun 15, 2026SEC filing |
| BOGER JOSHUA SDirector, 10% Owner | Open market purchaseDerivative security10b5-1 plan not indicated | 955,414 | — | — | 955,414 | Jun 11, 2026 | Jun 15, 2026SEC filing |
| ALAM JOHN JCEO & President, Director, 10% Owner | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| BOGER JOSHUA SDirector, 10% Owner | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| Gregoire SylvieDirector, 10% Owner | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| Hollingsworth Jane HDirector | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| Poulton Jeffrey V.Director | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| Quigley DavidDirector | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| Sabbagh MarwanDirector | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| ZAVRL FRANKDirector | Grant / awardDerivative security10b5-1 plan not indicated | 8,150 | — | — | 8,150 | Jun 8, 2026 | Jun 10, 2026SEC filing |
| ALAM JOHN JCEO & President, Director, 10% Owner | Grant / awardDerivative security10b5-1 plan not indicated | 75,000 | — | — | 75,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
| Blackburn KellyEVP, Clinical Development | Grant / awardDerivative security10b5-1 plan not indicated | 30,000 | — | — | 30,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
| De Rosch MarkEVP, RA and GA and PgM | Grant / awardDerivative security10b5-1 plan not indicated | 30,000 | — | — | 30,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
| ELDER WILLIAM ROBERTCFO, GC & Secretary | Grant / awardDerivative security10b5-1 plan not indicated | 30,000 | — | — | 30,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
| Gregoire SylvieDirector, 10% Owner | Grant / awardDerivative security10b5-1 plan not indicated | 75,000 | — | — | 75,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
| Winton MatthewChief Commercial and Business | Grant / awardDerivative security10b5-1 plan not indicated | 30,000 | — | — | 30,000 | Feb 11, 2026 | Feb 13, 2026SEC filing |
Review the entire collected insider disclosure history with a free account.
Full collected history is available here after sign-in, separate from the public 12-month window. It is not an exhaustive trading history.
The largest open-market transaction by reported value in the public window was an open-market purchase by BOGER JOSHUA S on Jun 11, 2026: $2,999,999.96, involving 955,414 shares. Reported price: $3.14.
0 public-window transactions explicitly indicate a 10b5-1 plan. A missing indication is not proof that a transaction was discretionary. Prices and values are shown only when reported; unavailable fields are not filled with zero.
Collected disclosures show 0 open-market purchases and 0 sales with transaction dates in the trailing 30 days ending Oct 15, 2026. Net reported purchase less sale value is $0.00. The latest collected disclosure data is as of Jun 15, 2026. These counts do not represent every insider action.
0 distinct insiders appear in collected disclosures for transaction dates in the trailing 30 days ending Oct 15, 2026. The latest collected Form 4 was filed on Jun 15, 2026. A filing date is not the transaction date.
This page shows 17 collected transactions dated in the trailing 12 months ending Oct 15, 2026. 0 older collected transactions are summarized outside this window and can be viewed here after sign-in. This is collected disclosure coverage, not exhaustive history; 10b5-1 plan status and derivative securities are labeled per record.
Insider data covers the trailing 12 months on public tables. Congressional tables cover all saved disclosures. Neither is an exhaustive history. Form 4 filing dates and congressional disclosure dates may differ from trade dates. Congressional amounts are ranges, not estimated dollar totals. Disclosure activity alone does not establish intent or predict returns.
From disclosure to research
Create a workspace for filing analysis and research notes. Filing-alert availability depends on your plan. Review the plan features separately; opening the plans page does not create an alert.